- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07610681
Midline Catheter Study
May 27, 2026 updated by: Children's Hospital of Fudan University
A Prospective Longitudinal Cohort Study on the Application of Mini-Midline Catheters in Pediatric Populations
The purpose of this study is to conduct a prospective longitudinal cohort observational study to analyze the catheterization success rate, catheter dwell time, as well as the incidence and risk factors of related complications in pediatric patients of different age groups; to explore the suitability and application efficacy of this type of catheter in different disease types and treatment scenarios; to optimize the venous access selection strategy for hospitalized pediatric patients, formulate targeted catheterization and maintenance standards, provide theoretical evidence for clinical practice, and improve patients' medical experience.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
428
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 201102
- Children's Hospital of Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Pediatric patients with indwelling mini midline catheters during hospitalization
Description
1.Inclusion Criteria:
- Children aged 1 day to 18 years;
- Indwelling midline catheters;
- Legally authorized guardians have signed the informed consent form.
2.Exclusion Criteria: Pediatric patients with vascular access other than indwelling midline catheters.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pediatric patients aged 1 day to 18 years who require midline catheter placement
|
No intervention.
This is a cohort study investigating the applicability and safety of mini midline catheters in pediatric populations.
All enrolled children receive standard clinical care for mini midline catheters (including placement, daily maintenance, and removal as indicated) consistent with pediatric vascular access guidelines.
The study aims to observe the natural clinical performance of the catheters without any intervention beyond routine clinical management.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety: Midline catheter-related complications and their severity,including: ① Catheter-related bloodstream infection (CRBSI) ② Venous thrombosis ③ Catheter occlusion ④ Phlebitis ⑤ Extravasation/infiltration
Time Frame: Catheter dwell time (from placement to removal; maximum follow-up: 30 days)
|
Catheter dwell time (from placement to removal; maximum follow-up: 30 days)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feasibility: First-attempt puncture success rate (%) ;
Time Frame: Blood return was achieved smoothly upon completion of the first puncture, within one minute of catheter placement.
|
Blood return was achieved smoothly upon completion of the first puncture, within one minute of catheter placement.
|
|
Catheterization duration(minutes)
Time Frame: From initial skin puncture to catheter fixation, assessed intraprocedurally
|
From initial skin puncture to catheter fixation, assessed intraprocedurally
|
|
Catheter dwell time(days)
Time Frame: From successful catheter placement to removal, maximum follow-up of 30 days
|
From successful catheter placement to removal, maximum follow-up of 30 days
|
|
Unplanned extubation rate(%)
Time Frame: Within 30 days post-insertion
|
Within 30 days post-insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 30, 2026
Study Registration Dates
First Submitted
January 13, 2026
First Submitted That Met QC Criteria
May 27, 2026
First Posted (Actual)
May 28, 2026
Study Record Updates
Last Update Posted (Actual)
May 28, 2026
Last Update Submitted That Met QC Criteria
May 27, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- CHFudanU0113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Health
-
University of South CarolinaCompletedParents | Child Behavior | Child Health | Child, PreschoolUnited States
-
Chinese University of Hong KongCompletedChild HealthHong Kong
-
University of UtahRobert Wood Johnson FoundationCompletedChild Abuse | Primary Health Care | Child WelfareUnited States
-
Linkoeping UniversityUppsala University; Örebro University, Sweden; Stockholm UniversityRecruiting
-
Center for Primary Care and Public Health (Unisante)...Swiss Tropical & Public Health Institute; Ecole Polytechnique Fédérale de Lausanne and other collaboratorsCompleted
-
Center for Primary Care and Public Health (Unisante)...Swiss Tropical & Public Health Institute; Ifakara Health Institute; University... and other collaboratorsCompleted
-
University of CalgaryAlberta Children's Hospital; Provincial Health Services Authority; Brain Canada; MindSea Development and other collaboratorsRecruitingParenting | Child Development | Child Mental Health | Parent Mental HealthCanada
-
Oral Health Centre of Expertise in Western NorwayEducational storytelling forlag og filmCompletedChild Abuse | Oral Health | Child Neglect | Child Maltreatment | Child Sexual Abuse | Dental NeglectNorway
-
Integrate HealthAlbert Einstein College of Medicine; Montefiore Medical Center; City University... and other collaboratorsUnknownMaternal-Child Health Services | Health Service UtilizationTogo
-
Integrate HealthAlbert Einstein College of Medicine; Montefiore Medical Center; City University... and other collaboratorsUnknownMaternal and Child Health | Health Service UtilizationTogo
Clinical Trials on Mini midline catheters
-
Hospital El CruceRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedDiabetes Mellitus, Type 2 | Diabetes Complications | Upper Extremity Deep Vein Thrombosis | Catheter-Related Infections | Catheterization, PeripheralSpain
-
Sir Run Run Shaw HospitalNot yet recruiting
-
Sir Run Run Shaw HospitalCompletedCatheter ComplicationsChina
-
Copernicus Memorial HospitalRecruitingLumbar Disc Degeneration | Lower Back Pain Chronic | Degenerative Disc Disease(DDD) | Lumbar Degenerative DiseasePoland
-
Sir Run Run Shaw HospitalCompleted
-
Region Jönköping CountyCompletedDifficult Intravenous AccessSweden
-
Sir Run Run Shaw HospitalCompleted
-
Hiroki YamaueKatsunari TakifujiUnknown
-
Biosense Webster, Inc.TerminatedAtrial FibrillationUnited States, United Kingdom, Italy, Czechia, Belgium, Hungary